Efficacy and safety of edifoligide.
Parolari
Alessandro
A
Alamanni
Francesco
F
Tremoli
Elena
E
Biglioli
Paolo
P
D001026:Coronary Artery Bypass; D004247:DNA / Q000627:therapeutic use*; D050684:E2F Transcription Factors; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D015316:Genetic Therapy; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D009841:Oligonucleotides / Q000627:therapeutic use*; D012501:Saphenous Vein / Q000187:drug effects* / Q000637:transplantation*; D019737:Transplants; D014654:Vascular Patency / Q000187:drug effects*
D050684:E2F Transcription Factors; D005343:Fibrinolytic Agents; D009841:Oligonucleotides; C502518:edifoligide; D004247:DNA